Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
11,415
+317
+3% +$6.78K ﹤0.01% 1586
2026
Q1
$224K Buy
11,098
+838
+8% +$18.6K ﹤0.01% 1423
2025
Q4
$197K Sell
10,260
-444
-4% -$9.34K ﹤0.01% 1395
2025
Q3
$258K Sell
10,704
-3,198
-23% -$74.7K ﹤0.01% 1240
2025
Q2
$271K Sell
13,902
-2,018
-13% -$29.8K ﹤0.01% 1179
2025
Q1
$205K Sell
15,920
-72
-0.5% -$1.16K ﹤0.01% 1261
2024
Q4
$276K Buy
15,992
+2,331
+17% +$46.6K ﹤0.01% 1159
2024
Q3
$308K Buy
13,661
+1,436
+12% +$32.8K ﹤0.01% 1083
2024
Q2
$302K Sell
12,225
-2,930
-19% -$83.2K ﹤0.01% 1058
2024
Q1
$499K Sell
15,155
-359
-2% -$12.2K 0.01% 943
2023
Q4
$564K Buy
15,514
+78
+0.5% +$2.68K 0.01% 890
2023
Q3
$567K Sell
15,436
-365
-2% -$14.5K 0.01% 838
2023
Q2
$605K Buy
15,801
+614
+4% +$22.7K 0.01% 831
2023
Q1
$622K Buy
15,187
+378
+3% +$15.8K 0.01% 840
2022
Q4
$514K Sell
14,809
-13
-0.1% -$455 0.01% 889
2022
Q3
$411K Buy
14,822
+160
+1% +$5.19K 0.01% 907
2022
Q2
$434K Buy
14,662
+773
+6% +$26K 0.01% 910
2022
Q1
$566K Sell
13,889
-44
-0.3% -$1.89K 0.01% 840
2021
Q4
$667K Sell
13,933
-222
-2% -$9.96K 0.01% 785
2021
Q3
$587K Sell
14,155
-723
-5% -$28.8K 0.01% 812
2021
Q2
$672K Buy
14,878
+4,477
+43% +$209K 0.01% 776
2021
Q1
$460K Sell
10,401
-1,941
-16% -$73.3K 0.01% 813
2020
Q4
$429K Sell
12,342
-53
-0.4% -$1.49K 0.01% 811
2020
Q3
$215K Buy
12,395
+540
+5% +$9.41K 0.01% 960
2020
Q2
$195K Buy
+11,855
New +$180K 0.01% 976

Other funds holding ADNT

Xponance's ADNT Position: Q2 2026 in Review

Xponance increased its Adient (ADNT) stake by 2.9% in Q2 2026, buying an estimated $6.78K and bringing the position to 11,415 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #1586.

Xponance first reported a position in ADNT in Q2 2020 and has held it in 25 quarters since. The position peaked at $672K in Q2 2021. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Xponance held 11,415 shares of Adient worth $210K as of Q2 2026.
  • Xponance bought 317 Adient shares in Q2 2026, an estimated $6.78K.
  • Adient made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1586 holding.
  • Xponance first reported a position in Adient in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Adient position peaked at $672K in Q2 2021.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.